The Global Market for Dental Imaging Systems to Reach $3.4 Billion by 2023
August 02, 2018
WELLESLEY, Mass., Aug 02, 2018, 2018 – Due to being able to treat and diagnose oral complications in advance, along with independently performing small procedures, the global market for dental imaging systems is experiencing solid growth, according to a recent report from BCC Research.
As outlined in the report “Dental Imaging Systems: Global Markets to 2023,” the global market for dental imaging systems was valued at $2.2 billion in 2018. The market is estimated to reach $3.4 billion by 2023, indicating a compound annual growth rate (CAGR) of 9.2%.
Dental imaging can be performed using conventional films, digital sensors, cone-beam computed tomography (CBCT) scanners and intra-oral cameras, depending on the purpose and complexity of diagnosis. Using digital imaging techniques may offer reduced radiation exposure, when compared with conventional film radiography.
Research Highlights
- North America holds the largest market for dental imaging, followed by Europe. This is a result of the technological advancements in dental imaging, increasing prevalence of dental diseases, rise in healthcare expenditure and improved healthcare infrastructure in the region.
- In the coming five years, growth in the dental imaging market is likely to be focused in the Asia-Pacific region. The growth can be attributed to aging populations, growing prevalence of dental disorders, increasing awareness of dental care, growing availability of advanced dental imaging systems and rising disposable incomes.
- The change from analogue to digital radiography has not only made the process simpler and faster, but has also made image storage, manipulation (brightness/contrast, image cropping, etc.) and retrieval easier.
“Dental radiography and imaging can help the dental practitioner evaluate and definitively diagnose many oral diseases and conditions, to find hidden dental structures, malignant or benign masses, and identify bone-loss and cavities,” the report notes. “It is also used to identify impacted wisdom teeth, jaw bone pathologies, temporomandibular joint conditions, as well as aid in the planning and execution of therapeutic procedures like implants, root canal treatments and other maxillofacial surgeries.”
Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.
Dental Imaging Systems: Global Markets to 2023( HLC215A )
Publish Date: Jun 2018
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
- 3D Protein Structure Analysis: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development